ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Recalls and Alerts

Class 4 Caution in Use

Class 4 caution in use-Rabeprazole sodium 10 & 20mg GR tablets

Bristol Laboratories Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the batches in the table for Rabeprazole sodium 10mg and 20mg gastro-resistant tablets do not contain the most up to date safety information.

 

MHRA Drug alert date: 9th January 2025

 

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-rabeprazole-sodium-10mg-and-20mg-gastro-resistant-tablets-el-25-a-slash-01?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2ea2f68a-a589-4a59-9548-7c91851e5608&utm_content=immediately

 

Pip code

Product description

Supplier

Batch Numbers

8093007

RABEPRAZOLE GR TAB 10MG

Bristol Laboratories Limited

LC72047  LC74744  LC76888

8092991

RABEPRAZOLE GR TAB 20MG

Bristol Laboratories Limited

LC72045  LC75526  LC76906

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For medical information enquiries please contact at: email: info@bristol-labs.co.uk, or telephone: +44 (0) 1442 200 922

 

For stock control enquiries please contact at email: notifications@bristol-labs.co.uk, or telephone: +44 (0) 1442 200 922